Jameson, A.Fylan, BethBristow, Greg C.Cardno, A.Dalton, C.Sagoo, G.Sohal, J.McLean, Samantha2023-09-142023-09-292023-09-142023-09-2910/08/2022Jameson A, Fylan B, Bristow GC et al (2022) Pharmacogenomics is the future of prescribing in psychiatry. Pharmaceutical Journal. 209: 7964.RMSID:212758128http://hdl.handle.net/10454/19587YesPatients' pharmacogenetic data could be used to improve adherence to antipsychotic medication by increasing the likelihood of therapeutic response and reducing the prevalence of adverse drug reactions.en(c) 2022 The Pharmaceutical Journal. Full-text reproduced in accordance with the publisher's self-archiving policy.PharmacogenomicsPsychiatryPrescribingTherapeutic responseAdverse drug reactionsArticlehttps://doi.org/10.1211/PJ.2022.1.152215Unspecified2023-09-14